Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune Disorders, Rare / Genetic Disorders, Cardiovascular Disorders, Metabolic Disorders, Blood Disorders, Neurological Disorders, Ophthalmic Disorders and Other Therapeutic Areas), Scale of Operation (Discovery, Preclinical and Clinical) and Geography (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2021-2035

Name: Bioassay Services Market by Type of Therapy (Cell Therapy and Gene Therapy), Therapeutic Area (Oncological Disorders, Infectious Diseases, Autoimmune
Brand: Roots Analysis
SKU: BD97AC5FA7B9EN
Price: 4799 USD
Availability: InStock

July 2023 | 310 pages | ID: BD97AC5FA7B9EN
Roots Analysis

US$ 4,799.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Abstracts
Contents

The bioassay services market for cell therapy and gene therapy is expected to reach USD 155 million in 2021 anticipated to grow at a CAGR of 30.1% during the forecast period 2021-2032

The preference for cell and gene therapies in addressing severe medical conditions has led to a significant increase in their development and approval for treating various diseases. Currently, more than 30 therapies have been approved, with over 1,200 in different stages of development. This rise in favorability positions these advanced therapies to potentially become a highly esteemed segment in the biopharmaceutical industry.

Despite their potential, developing cell and gene therapies is complex and financially demanding. Consequently, outsourcing has become a favored approach, with companies relying heavily on specialized service providers to handle different aspects of their product development and manufacturing. The majority of biopharmaceutical companies prefer outsourcing, with a significant portion of their spending directed towards these services. Analytical testing services, including various types of testing like environmental, bioanalytical, chemistry, stability testing, method development, validation, and product characterization, have seen a notable surge in demand.

This increased demand for outsourcing analytical testing services has led to the emergence of specialized contract research organizations focusing on offering tailored bioassay services for cell and gene therapies. These organizations possess advanced technology and expertise, aiding in study optimization, cost efficiency, and timeline reduction. With ongoing efforts to enhance their offerings, the market for cell and gene therapy bioassay services is expected to consistently grow in the forecasted period.

Report Coverage

Detailed overview of the global cell & gene therapy bioanalytical testing services market, including company details (year of establishment, size, HQ, facilities), offerings (in vitro, in vivo), bioassay types, services offered (immunoassay, PCR, flow cytometry, etc.), and applications (cell therapy, gene therapy).
Competitive analysis of bioassay service providers globally, considering service strength, applicability, and supplier experience.
Profiles of key players in North America, Europe, and Asia-Pacific offering cell and gene therapy bioassay services, covering company overview, service portfolio, offerings, bioassay types, facilities, recent developments, and future outlook.
Market trend analysis of cell and gene therapy service providers based on offered services and application areas, with a map showing bioanalytical facility locations.
Analysis of global events attended by service providers, focusing on service types, application areas, and strategic initiatives.
Case study of the cell and gene therapy market landscape, including distribution by development phase, therapeutic areas, and developer types.
In-depth analyses of 260 cell therapy developers and 190 gene therapy developers anticipated to partner with bioassay service providers, based on company strength, pipeline maturity, and capabilities.

Key Market Companies

CCRM
Nexelis
Pacific BioLabs
PPD Laboratories
WuXi Advanced Therapies
AnaBioTec
Intertek Pharmaceutical Services
Lonza
Porton Bio

1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

2.1. Chapter Overview

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to Bioassays
3.3. Cell and Gene Therapy Bioassays
3.4. Importance of Bioassays in Cell and Gene Therapy
3.5. Challenges Related to Cell and Gene Therapy Bioassays
3.6. Role of Contract Service Providers and Prevalent Outsourcing Trends
3.7. Future Perspectives

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Cell and Gene Therapy Bioassay Service Providers: Overall Market Landscape
  4.2.1. Analysis by Year of Establishment
  4.2.2. Analysis by Company Size
  4.2.3. Analysis by Location of Headquarters
  4.2.4. Analysis by Company Size and Location of Headquarters
  4.2.5. Analysis by Location of Bioanalytical Facilities
  4.2.6. Analysis by Type of Bioassay(s) Offered
  4.2.7. Analysis by Types of Offering(s) of Bioassay
  4.2.8. Analysis of Type of Bioanalytical Service(s) Offered
  4.2.9. Analysis by Application Area

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Methodology
5.3. Key Parameters
5.4. Competitiveness Analysis: Companies Offering Cell and Gene Therapy Bioassay Services in North America
5.5. Competitiveness Analysis: Companies Offering Cell and Gene Therapy Bioassay Services in Europe and Asia-Pacific

6. CELL AND GENE THERAPY BIOASSAY SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

6.1. Chapter Overview
6.2. CCRM
  6.2.1. Company Overview
  6.2.2. Cell and Gene Therapy Bioassay Service Portfolio
  6.2.3. Recent Developments and Future Outlook
6.3. Nexelis
  6.3.1. Company Overview
  6.3.2. Cell and Gene Therapy Bioassay Service Portfolio
  6.3.3. Recent Developments and Future Outlook
6.4. Pacific BioLabs
  6.4.1. Company Overview
  6.4.2. Cell and Gene Therapy Bioassay Service Portfolio
  6.4.3. Recent Developments and Future Outlook
6.5. PPD Laboratories
  6.5.1. Company Overview
  6.5.2. Cell and Gene Therapy Bioassay Service Portfolio
  6.5.3. Recent Developments and Future Outlook
6.6. WuXi Advanced Therapies
  6.6.1. Company Overview
  6.6.2. Cell and Gene Therapy Bioassay Service Portfolio
  6.6.3. Recent Developments and Future Outlook

7. CELL AND GENE THERAPY BIOASSAY SERVICE PROVIDERS IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES

7.1. Chapter Overview
7.2. AnaBioTec
  7.2.1. Company Overview
  7.2.2. Cell and Gene Therapy Bioassay Service Portfolio
  7.2.3. Recent Developments and Future Outlook
7.3. Intertek Pharmaceutical Services
  7.3.1. Company Overview
  7.3.2. Cell and Gene Therapy Bioassay Service Portfolio
  7.3.3. Recent Developments and Future Outlook
7.4. Lonza
  7.4.1. Company Overview
  7.4.2. Cell and Gene Therapy Bioassay Service Portfolio
  7.4.3. Recent Developments and Future Outlook
7.5. Porton Bio
  7.5.1. Company Overview
  7.5.2. Cell and Gene Therapy Bioassay Service Portfolio
  7.5.3. Recent Developments and Future Outlook

8. MARKET TREND ANALYSIS

8.1. Chapter Overview
8.2 Cell and Gene Therapy Bioassay Service Providers: Analysis by Type of Bioanalytical Service(s) Offered and Application Area
8.3. Cell and Gene Therapy Bioassay Service Providers: Analysis by Type of Bioassay(s) and Type of Bioanalytical Service(s) Offered
8.4 Cell and Gene Therapy Bioassay Service Providers: Analysis by Location of Bioanalytical facilities
  8.4.1. Players with Bioanalytical Facilities in US
  8.4.2. Players with Bioanalytical Facilities in Rest of the World

9. GLOBAL EVENT AND STRATEGIC INITIATIVE ANALYSIS

9.1. Chapter Overview
9.2. Cell and Gene Therapy Bioassay Service Providers: List of Event and Strategic Initiatives
  9.2.1. Analysis by Year of Event
  9.2.2. Analysis by Type of Event
  9.2.3. Analysis by Year and Type of Event
  9.2.4. Analysis by Type of Services Involved
  9.2.5. Analysis by Application Area
  9.2.6. Prominent Players: Analysis by Number of Events and Strategic Initiatives

10. CASE STUDY: MARKET LANDSCAPE OF CELL AND GENE THERAPIES

10.1. Chapter Overview
10.2. Cell Therapy Market
  10.2.1. T-Cell Immunotherapies: Development Pipeline
    10.2.1.1. Analysis by Type of Product
  10.2.2. CAR-T Cell Therapies: Development Pipeline
    10.2.2.1. Analysis by Phase of Development
    10.2.2.2. Analysis by Therapeutic Area
    10.2.2.3. Analysis by Type of Developer
    10.2.2.4. Key Industry Players: Analysis by Number of CAR-T Cell Therapies in Development
  10.2.3. TCR-based Therapies: Development Pipeline
    10.2.3.1. Analysis by Phase of Development
    10.2.3.2. Analysis by Therapeutic Area
    10.2.3.3. Analysis by Type of Developer
    10.2.3.4. Key Industry Players: Analysis by Number of TCR-based Therapies in Development
  10.2.4. TIL-based Therapies: Development Pipeline
    10.2.4.1. Analysis by Phase of Development
    10.2.4.2. Analysis by Therapeutic Area
    10.2.4.3. Analysis by Type of Developer
    10.2.4.4. Key Industry Players: Analysis by Number of TIL-based Therapies in Development
10.3. Gene Therapy Market
  10.3.1. Gene Therapy Market: Clinical and Commercial Pipeline
    10.3.1.1. Analysis by Phase of Development
    10.3.1.2. Analysis by Therapeutic Area
  10.3.2. Gene Therapy Market: Development Pipeline
    10.3.2.1. Analysis by Phase of Development
    10.3.2.2. Analysis by Therapeutic Area

11. LIKELY PARTNERS FOR CELL THERAPY BIOASSAY SERVICE PROVIDERS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Potential Strategic Partners for Cell Therapy Bioassay Service Providers
  11.3.1. Likely Partner Opportunities for Stem Cell Therapy Bioassay Service Providers
  11.3.2. Likely Partner Opportunities for CAR-T Therapy Bioassay Service Providers
  11.3.3. Likely Partner Opportunities for Dendritic Cell Therapy Bioassay Service Providers
  11.3.4. Likely Partner Opportunities for Tumor Cell Therapy Bioassay Service Providers
  11.3.5. Likely Partner Opportunities for NK Cell Therapy Bioassay Service Providers

12. LIKELY PARTNERS FOR GENE THERAPY BIOASSAY SERVICE PROVIDERS

12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Potential Strategic Partners for Gene Therapy Bioassay Service Providers
  12.3.1. Likely Partner Opportunities in North America
  12.3.2. Likely Partner Opportunities in Europe
  12.3.3. Likely Partner Opportunities in Asia-Pacific

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Global Cell and Gene Therapy Bioassay Services Market
  13.3.1. Global Cell and Gene Therapy Bioassay Services Market: Distribution by Type of Therapy
  13.3.2. Global Cell and Gene Therapy Bioassay Services Market: Distribution by Therapeutic Area
  13.3.3. Global Cell and Gene Therapy Bioassay Services Market: Distribution by Scale of Operation
  13.3.4. Global Cell and Gene Therapy Bioassay Services Market: Distribution by Geography
13.4. Cell Therapy Bioassay Services Market in North America, 2021-2035
  13.4.1. Cell Therapy Bioassay Services Market in North America: Distribution by Therapeutic Area, 2021-2035
    13.4.1.1. Cell Therapy Bioassay Services Market for Oncological Disorders in North America, 2021-2035
    13.4.1.2. Cell Therapy Bioassay Services Market for Infectious Diseases in North America, 2021-2035
    13.4.1.3. Cell Therapy Bioassay Services Market for Autoimmune Disorders in North America, 2021-2035
    13.4.1.4. Cell Therapy Bioassay Services Market for Rare / Genetic Disorders in North America, 2021-2035
    13.4.1.5. Cell Therapy Bioassay Services Market for Cardiovascular Disorders in North America, 2021-2035
    13.4.1.6. Cell Therapy Bioassay Services Market for Metabolic Disorders in North America, 2021-2035
    13.4.1.7. Cell Therapy Bioassay Services Market for Blood Disorders in North America, 2021-2035
    13.4.1.8. Cell Therapy Bioassay Services Market for Neurological Disorders in North America, 2021-2035
    13.4.1.9. Cell Therapy Bioassay Services Market for Ophthalmic Disorders in North America, 2021-2035
    13.4.1.10. Cell Therapy Bioassay Services Market for Other Therapeutic Areas in North America, 2021-2035
  13.4.2. Cell Therapy Bioassay Services Market in North America: Distribution by Scale of Operation, 2021-2035
    13.4.2.1. Cell Therapy Bioassay Services Market for Discovery Operations in North America, 2021-2035
    13.4.2.2. Cell Therapy Bioassay Services Market for Preclinical Operations in North America, 2021-2035
    13.4.2.3. Cell Therapy Bioassay Services Market for Clinical Operations in North America, 2021-2035
13.5. Cell Therapy Bioassay Services Market in Europe, 2021-2035
  13.5.1. Cell Therapy Bioassay Services Market in Europe: Distribution by Therapeutic Area, 2021-2035
    13.5.1.1. Cell Therapy Bioassay Services Market for Oncological Disorders in Europe, 2021-2035
    13.5.1.2. Cell Therapy Bioassay Services Market for Infectious Diseases in Europe, 2021-2035
    13.5.1.3. Cell Therapy Bioassay Services Market for Autoimmune Disorders in Europe, 2021-2035
    13.5.1.4. Cell Therapy Bioassay Services Market for Rare / Genetic Disorders in Europe, 2021-2035
    13.5.1.5. Cell Therapy Bioassay Services Market for Cardiovascular Disorders in Europe, 2021-2035
    13.5.1.6. Cell Therapy Bioassay Services Market for Metabolic Disorders in Europe, 2021-2035
    13.5.1.7. Cell Therapy Bioassay Services Market for Blood Disorders in Europe, 2021-2035
    13.5.1.8. Cell Therapy Bioassay Services Market for Neurological Disorders in Europe, 2021-2035
    13.5.1.9. Cell Therapy Bioassay Services Market for Ophthalmic Disorders in Europe, 2021-2035
    13.5.1.10. Cell Therapy Bioassay Services Market for Other Therapeutic Areas in Europe, 2021-2035
  13.5.2. Cell Therapy Bioassay Services Market in Europe: Distribution by Scale of Operation, 2021-2035
    13.5.2.1. Cell Therapy Bioassay Services Market for Discovery Operations in Europe, 2021-2035
    13.5.2.2. Cell Therapy Bioassay Services Market for Preclinical Operations in Europe, 2021-2035
    13.5.2.3. Cell Therapy Bioassay Services Market for Clinical Operations in Europe, 2021-2035
13.6. Cell Therapy Bioassay Services Market in Asia-Pacific, 2021-2035
  13.6.1. Cell Therapy Bioassay Services Market in Asia-Pacific: Distribution by Therapeutic Area, 2021-2035
    13.6.1.1. Cell Therapy Bioassay Services Market for Oncological Disorders in Asia-Pacific, 2021-2035
    13.6.1.2. Cell Therapy Bioassay Services Market for Infectious Diseases in Asia-Pacific, 2021-2035
    13.6.1.3. Cell Therapy Bioassay Services Market for Autoimmune Disorders in Asia-Pacific, 2021-2035
    13.6.1.4. Cell Therapy Bioassay Services Market for Rare / Genetic Disorders in Asia-Pacific, 2021-2035
    13.6.1.5. Cell Therapy Bioassay Services Market for Cardiovascular Disorders in Asia-Pacific, 2021-2035
    13.6.1.6. Cell Therapy Bioassay Services Market for Metabolic Disorders in Asia-Pacific, 2021-2035
    13.6.1.7. Cell Therapy Bioassay Services Market for Blood Disorders in Asia-Pacific, 2021-2035
    13.6.1.8. Cell Therapy Bioassay Services Market for Neurological Disorders in Asia-Pacific, 2021-2035
    13.6.1.9. Cell Therapy Bioassay Services Market for Ophthalmic Disorders in Asia-Pacific, 2021-2035
    13.6.1.10. Cell Therapy Bioassay Services Market for Other Therapeutic Areas in Asia-Pacific, 2021-2035
  13.6.2. Cell Therapy Bioassay Services Market in Asia-Pacific: Distribution by Scale of Operation, 2021-2035
    13.6.2.1. Cell Therapy Bioassay Services Market for Discovery Operations in Asia-Pacific, 2021-2035
    13.6.2.2. Cell Therapy Bioassay Services Market for Preclinical Operations in Asia-Pacific, 2021-2035
    13.6.2.3. Cell Therapy Bioassay Services Market for Clinical Operations in Asia-Pacific, 2021-2035
13.7. Cell Therapy Bioassay Services Market in Latin America, 2021-2035
  13.7.1. Cell Therapy Bioassay Services Market in Latin America: Distribution by Therapeutic Area, 2021-2035
    13.7.1.1. Cell Therapy Bioassay Services Market for Oncological Disorders in Latin America, 2021-2035
    13.7.1.2. Cell Therapy Bioassay Services Market for Infectious Diseases in Latin America, 2021-2035
    13.7.1.3. Cell Therapy Bioassay Services Market for Autoimmune Disorders in Latin America, 2021-2035
    13.7.1.4. Cell Therapy Bioassay Services Market for Rare / Genetic Disorders in Latin America, 2021-2035
    13.7.1.5. Cell Therapy Bioassay Services Market for Cardiovascular Disorders in Latin America, 2021-2035
    13.7.1.6. Cell Therapy Bioassay Services Market for Metabolic Disorders in Latin America, 2021-2035
    13.7.1.7. Cell Therapy Bioassay Services Market for Blood Disorders in Latin America, 2021-2035
    13.7.1.8. Cell Therapy Bioassay Services Market for Neurological Disorders in Latin America, 2021-2035
    13.7.1.9. Cell Therapy Bioassay Services Market for Ophthalmic Disorders in Latin America, 2021-2035
    13.7.1.10. Cell Therapy Bioassay Services Market for Other Therapeutic Areas in Latin America, 2021-2035
  13.7.2. Cell Therapy Bioassay Services Market in Latin America: Distribution by Scale of Operation, 2021-2035
    13.7.2.1. Cell Therapy Bioassay Services Market for Discovery Operations in Latin America, 2021-2035
    13.7.2.2. Cell Therapy Bioassay Services Market for Preclinical Operations in Latin America, 2021-2035
    13.7.2.3. Cell Therapy Bioassay Services Market for Clinical Operations in Latin America, 2021-2035
13.8. Cell Therapy Bioassay Services Market in MENA, 2021-2035
  13.8.1. Cell Therapy Bioassay Services Market in MENA: Distribution by Therapeutic Area, 2021-2035
    13.8.1.1. Cell Therapy Bioassay Services Market for Oncological Disorders in MENA, 2021-2035
    13.8.1.2. Cell Therapy Bioassay Services Market for Infectious Diseases in MENA, 2021-2035
    13.8.1.3. Cell Therapy Bioassay Services Market for Autoimmune Disorders in MENA, 2021-2035
    13.8.1.4. Cell Therapy Bioassay Services Market for Rare / Genetic Disorders in MENA, 2021-2035
    13.8.1.5. Cell Therapy Bioassay Services Market for Cardiovascular Disorders in MENA, 2021-2035
    13.8.1.6. Cell Therapy Bioassay Services Market for Metabolic Disorders in MENA, 2021-2035
    13.8.1.7. Cell Therapy Bioassay Services Market for Blood Disorders in MENA, 2021-2035
    13.8.1.8. Cell Therapy Bioassay Services Market for Neurological Disorders in MENA, 2021-2035
    13.8.1.9. Cell Therapy Bioassay Services Market for Ophthalmic Disorders in MENA, 2021-2035
    13.8.1.10. Cell Therapy Bioassay Services Market for Other Therapeutic Areas in MENA, 2021-2035
  13.8.2. Cell Therapy Bioassay Services Market in MENA: Distribution by Scale of Operation, 2021-2035
    13.8.2.1. Cell Therapy Bioassay Services Market for Discovery Operations in MENA, 2021-2035
    13.8.2.2. Cell Therapy Bioassay Services Market for Preclinical Operations in MENA, 2021-2035
    13.8.2.3. Cell Therapy Bioassay Services Market for Clinical Operations in MENA, 2021-2035
13.9. Gene Therapy Bioassay Services Market in North America, 2021-2035
  13.9.1. Gene Therapy Bioassay Services Market in North America: Distribution by Therapeutic Area, 2021-2035
    13.9.1.1. Gene Therapy Bioassay Services Market for Oncological Disorders in North America, 2021-2035
    13.9.1.2. Gene Therapy Bioassay Services Market for Infectious Diseases in North America, 2021-2035
    13.9.1.3. Gene Therapy Bioassay Services Market for Autoimmune Disorders in North America, 2021-2035
    13.9.1.4. Gene Therapy Bioassay Services Market for Rare / Genetic Disorders in North America, 2021-2035
    13.9.1.5. Gene Therapy Bioassay Services Market for Cardiovascular Disorders in North America, 2021-2035
    13.9.1.6. Gene Therapy Bioassay Services Market for Metabolic Disorders in North America, 2021-2035
    13.9.1.7. Gene Therapy Bioassay Services Market for Blood Disorders in North America, 2021-2035
    13.9.1.8. Gene Therapy Bioassay Services Market for Neurological Disorders in North America, 2021-2035
    13.9.1.9. Gene Therapy Bioassay Services Market for Ophthalmic Disorders in North America, 2021-2035
    13.9.1.10. Gene Therapy Bioassay Services Market for Other Therapeutic Areas in North America, 2021-2035
  13.9.2. Gene Therapy Bioassay Services Market in North America: Distribution by Scale of Operation, 2021-2035
    13.9.2.1. Gene Therapy Bioassay Services Market for Discovery Operations in North America, 2021-2035
    13.9.2.2. Gene Therapy Bioassay Services Market for Preclinical Operations in North America, 2021-2035
    13.9.2.3. Gene Therapy Bioassay Services Market for Clinical Operations in North America, 2021-2035
13.10. Gene Therapy Bioassay Services Market in Europe, 2021-2035
  13.10.1. Gene Therapy Bioassay Services Market in Europe: Distribution by Therapeutic Area, 2021-2035
    13.10.1.1. Gene Therapy Bioassay Services Market for Oncological Disorders in Europe, 2021-2035
    13.10.1.2. Gene Therapy Bioassay Services Market for Infectious Diseases in Europe, 2021-2035
    13.10.1.3. Gene Therapy Bioassay Services Market for Autoimmune Disorders in Europe, 2021-2035
    13.10.1.4. Gene Therapy Bioassay Services Market for Rare / Genetic Disorders in Europe, 2021-2035
    13.10.1.5. Gene Therapy Bioassay Services Market for Cardiovascular Disorders in Europe, 2021-2035
    13.10.1.6. Gene Therapy Bioassay Services Market for Metabolic Disorders in Europe, 2021-2035
    13.10.1.7. Gene Therapy Bioassay Services Market for Blood Disorders in Europe, 2021-2035
    13.10.1.8. Gene Therapy Bioassay Services Market for Neurological Disorders in Europe, 2021-2035
    13.10.1.9. Gene Therapy Bioassay Services Market for Ophthalmic Disorders in Europe, 2021-2035
    13.10.1.10. Gene Therapy Bioassay Services Market for Other Therapeutic Areas in Europe, 2021-2035
  13.10.2. Gene Therapy Bioassay Services Market in Europe: Distribution by Scale of Operation, 2021-2035
    13.10.2.1. Gene Therapy Bioassay Services Market for Discovery Operations in Europe, 2021-2035
    13.10.2.2. Gene Therapy Bioassay Services Market for Preclinical Operations in Europe, 2021-2035
    13.10.2.3. Gene Therapy Bioassay Services Market for Clinical Operations in Europe, 2021-2035
13.11. Gene Therapy Bioassay Services Market in Asia-Pacific, 2021-2035
  13.11.1. Gene Therapy Bioassay Services Market in Asia-Pacific: Distribution by Therapeutic Area, 2021-2035
    13.11.1.1. Gene Therapy Bioassay Services Market for Oncological Disorders in Asia-Pacific, 2021-2035
    13.11.1.2. Gene Therapy Bioassay Services Market for Infectious Diseases in Asia-Pacific, 2021-2035
    13.11.1.3. Gene Therapy Bioassay Services Market for Autoimmune Disorders in Asia-Pacific, 2021-2035
    13.11.1.4. Gene Therapy Bioassay Services Market for Rare / Genetic Disorders in Asia-Pacific, 2021-2035
    13.11.1.5. Gene Therapy Bioassay Services Market for Cardiovascular Disorders in Asia-Pacific, 2021-2035
    13.11.1.6. Gene Therapy Bioassay Services Market for Metabolic Disorders in Asia-Pacific, 2021-2035
    13.11.1.7. Gene Therapy Bioassay Services Market for Blood Disorders in Asia-Pacific, 2021-2035
    13.11.1.8. Gene Therapy Bioassay Services Market for Neurological Disorders in Asia-Pacific, 2021-2035
    13.11.1.9. Gene Therapy Bioassay Services Market for Ophthalmic Disorders in Asia-Pacific, 2021-2035
    13.11.1.10. Gene Therapy Bioassay Services Market for Other Therapeutic Areas in Asia-Pacific, 2021-2035
  13.11.2. Gene Therapy Bioassay Services Market in Asia-Pacific: Distribution by Scale of Operation, 2021-2035
    13.11.2.1. Gene Therapy Bioassay Services Market for Discovery Operations in Asia-Pacific, 2021-2035
    13.11.2.2. Gene Therapy Bioassay Services Market for Preclinical Operations in Asia-Pacific, 2021-2035
    13.11.2.3. Gene Therapy Bioassay Services Market for Clinical Operations in Asia-Pacific, 2021-2035
13.12. Gene Therapy Bioassay Services Market in Latin America, 2021-2035
  13.12.1. Gene Therapy Bioassay Services Market in Latin America: Distribution by Therapeutic Area, 2021-2035
    13.12.1.1. Gene Therapy Bioassay Services Market for Oncological Disorders in Latin America, 2021-2035
    13.12.1.2. Gene Therapy Bioassay Services Market for Infectious Diseases in Latin America, 2021-2035
    13.12.1.3. Gene Therapy Bioassay Services Market for Autoimmune Disorders in Latin America, 2021-2035
    13.12.1.4. Gene Therapy Bioassay Services Market for Rare / Genetic Disorders in Latin America, 2021-2035
    13.12.1.5. Gene Therapy Bioassay Services Market for Cardiovascular Disorders in Latin America, 2021-2035
    13.12.1.6. Gene Therapy Bioassay Services Market for Metabolic Disorders in Latin America, 2021-2035
    13.12.1.7. Gene Therapy Bioassay Services Market for Blood Disorders in Latin America, 2021-2035
    13.12.1.8. Gene Therapy Bioassay Services Market for Neurological Disorders in Latin America, 2021-2035
    13.12.1.9. Gene Therapy Bioassay Services Market for Ophthalmic Disorders in Latin America, 2021-2035
    13.12.1.10. Gene Therapy Bioassay Services Market for Other Therapeutic Areas in Latin America, 2021-2035
  13.12.2. Gene Therapy Bioassay Services Market in Latin America: Distribution by Scale of Operation, 2021-2035
    13.12.2.1. Gene Therapy Bioassay Services Market for Discovery Operations in Latin America, 2021-2035
    13.12.2.2. Gene Therapy Bioassay Services Market for Preclinical Operations in Latin America, 2021-2035
    13.12.2.3. Gene Therapy Bioassay Services Market for Clinical Operations in Latin America, 2021-2035
13.13. Gene Therapy Bioassay Services Market in MENA, 2021-2035
  13.13.1. Gene Therapy Bioassay Services Market in MENA: Distribution by Therapeutic Area, 2021-2035
    13.13.1.1. Gene Therapy Bioassay Services Market for Oncological Disorders in MENA, 2021-2035
    13.13.1.2. Gene Therapy Bioassay Services Market for Infectious Diseases in MENA, 2021-2035
    13.13.1.3. Gene Therapy Bioassay Services Market for Autoimmune Disorders in MENA, 2021-2035
    13.13.1.4. Gene Therapy Bioassay Services Market for Rare / Genetic Disorders in MENA, 2021-2035
    13.13.1.5. Gene Therapy Bioassay Services Market for Cardiovascular Disorders in MENA, 2021-2035
    13.13.1.6. Gene Therapy Bioassay Services Market for Metabolic Disorders in MENA, 2021-2035
    13.13.1.7. Gene Therapy Bioassay Services Market for Blood Disorders in MENA, 2021-2035
    13.13.1.8. Gene Therapy Bioassay Services Market for Neurological Disorders in MENA, 2021-2035
    13.13.1.9. Gene Therapy Bioassay Services Market for Ophthalmic Disorders in MENA, 2021-2035
    13.13.1.10. Gene Therapy Bioassay Services Market for Other Therapeutic Areas in MENA, 2021-2035
  13.13.2. Gene Therapy Bioassay Services Market in MENA: Distribution by Scale of Operation, 2021-2035
    13.13.2.1. Gene Therapy Bioassay Services Market for Discovery Operations in MENA, 2021-2035
    13.13.2.2. Gene Therapy Bioassay Services Market for Preclinical Operations in MENA, 2021-2035
    13.13.2.3. Gene Therapy Bioassay Services Market for Clinical Operations in MENA, 2021-2035

14. CONCLUSION

14.1. Chapter Overview

15. EXECUTIVE INSIGHTS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

More Publications

Need Help?

Ask a Question

Market Reports